Michael Benatar and Jonathan Katz were awarded a clinical research network grant from MDA to support their work on Clinical Procedures To Support Research (CAPTURE) project.
MDA in June announced the award of a clinical research network grant (CRNG) to Michael Benatar, M.D., Ph.D., at and Jonathan Katz, M.D.
Jie Jiang, postdoctoral fellow at the University of California – San Diego, was awarded an MDA development grant to improve understanding of ALS.
Dr. Fen-Biao Gao was awarded an MDA research grant to study the C9ORF72 repeat expansion, which is the most common genetic mutation known to cause ALS.
Dr. Eric Shoubridge of McGill University in Montreal, Québec, who was awarded an MDA research grant totaling $287,169 over three years to study a new mitochondrial gene linked to ALS.
Akashi Therapeutics announced that the FDA has cleared the way for the company to resume clinical development of HT-100 in boys with DMD.
New research, supported by MDA and the CMT Association, examines gene therapy in CMT.
MDA has awarded an MDA Venture Philanthropy (MVP) grant to Izumi Biosciences, Inc., to fund early-stage development of IZ10023, for use in people with ALS who are taking riluzole, the only drug approved by the U.S. Food and Drug Administration to treat ALS.
On Dec. 23, 2016 the FDA approved Spinraza for the treatment of SMA. In clinical trials to test Spinraza, participants who received treatment with the drug experienced life-changing outcomes they wouldn’t have been expected to achieve.
Strength, Science, and Stories of Inspiration (SSSI) and the Muscular Dystrophy Association (MDA) announced a new research funding mechanism for graduate students and postdoctoral trainees working in the muscle disease field.
